Q2 2026 13F filing
Updated 27 days ago147 disclosed positions worth $438.6M
Full holdings
Every line item disclosed in Q2 2026
| # | Stock | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|---|
| 1 | D DBC INVESCO DB COMMDY INDX TRCK | $28.2M | 1.06M | 6.43% | Unchanged |
| 2 | A AAVXF ABIVAX SA | $15.1M | 113.0K | 3.43% | Trimmed(-0.2%) |
| 3 | R RVMDW REVOLUTION MEDICINES INC | $12.5M | 67.0K | 2.86% | Trimmed(-3.4%) |
| 4 | D DFTX DEFINIUM THERAPEUTICS INC | $11.4M | 242.9K | 2.60% | Added(+30.7%) |
| 5 | I IMVT IMMUNOVANT INC | $10.7M | 277.9K | 2.44% | Added(+23.4%) |
| 6 | P PRAX PRAXIS PRECISION MEDICINES I | $10.1M | 30.2K | 2.31% | Added(+14.8%) |
| 7 | R RLAY RELAY THERAPEUTICS INC | $9.5M | 506.2K | 2.16% | Added(+20.0%) |
| 8 | A ALKS ALKERMES PLC | $9.4M | 179.3K | 2.14% | Added(+144.9%) |
| 9 | P PCVX VAXCYTE INC | $8.7M | 149.7K | 1.98% | Added(+20.1%) |
| 10 | T TNGX TANGO THERAPEUTICS INC | $8.1M | 260.1K | 1.85% | Added(+149.6%) |
| 11 | L LQDA LIQUIDIA CORPORATION | $7.8M | 97.9K | 1.78% | Trimmed(-1.9%) |
| 12 | C COGT COGENT BIOSCIENCES INC | $7.3M | 188.8K | 1.67% | Trimmed(-4.2%) |
| 13 | G GPCR STRUCTURE THERAPEUTICS INC | $7M | 130.8K | 1.60% | Added(+5.5%) |
| 14 | E ELVN ENLIVEN THERAPEUTICS INC | $7M | 137.9K | 1.60% | Added(+88.6%) |
| 15 | A AMLX AMYLYX PHARMACEUTICALS INC | $6.9M | 386.1K | 1.58% | Added(+9.7%) |
| 16 | S SYRE SPYRE THERAPEUTICS INC | $6.9M | 77.8K | 1.57% | Trimmed(-46.8%) |
| 17 | L LBRX LB PHARMACEUTICALS INC | $6.9M | 211.5K | 1.57% | Added(+21.8%) |
| 18 | C CYTK CYTOKINETICS INC | $6.6M | 78.0K | 1.52% | Added(+33.0%) |
| 19 | B BEPC C4 THERAPEUTICS INC | $6.3M | 1.35M | 1.44% | — |
| 20 | T TYRA TYRA BIOSCIENCES INC | $5.9M | 184.8K | 1.35% | Added(+40.7%) |
| 21 | A ALMS ALUMIS INC | $5.6M | 200.0K | 1.28% | Added(+77.1%) |
| 22 | P PHVS PHARVARIS N V | $5.5M | 160.5K | 1.27% | Added(+64.0%) |
| 23 | T TARS TARSUS PHARMACEUTICALS INC | $5.5M | 87.1K | 1.25% | Added(+65.9%) |
| 24 | C CMPS COMPASS PATHWAYS PLC | $5.3M | 371.1K | 1.20% | Added(+1.9%) |
| 25 | D DNTH DIANTHUS THERAPEUTICS INC | $5M | 51.1K | 1.14% | Added(+43.7%) |
| 26 | N NRIX NURIX THERAPEUTICS INC | $4.9M | 203.7K | 1.13% | Trimmed(-10.1%) |
| 27 | A AXSM AXSOME THERAPEUTICS INC. | $4.9M | 20.2K | 1.13% | Trimmed(-1.2%) |
| 28 | T TVTX TRAVERE THERAPEUTICS INC | $4.9M | 86.2K | 1.12% | Added(+137.4%) |
| 29 | V VERA VERA THERAPEUTICS INC | $4.5M | 105.9K | 1.04% | Added(+53.0%) |
| 30 | N NVDA NVIDIA CORPORATION | $4.4M | 21.8K | 0.99% | Trimmed(-2.8%) |
| 31 | G GHRS GH RESEARCH PLC | $4.3M | 158.8K | 0.97% | Trimmed(-25.5%) |
| 32 | ? N/A PALISADE BIO INC | $4.2M | 2.03M | 0.97% | Added(+0.6%) |
| 33 | A ARGX ARGENX SE | $4.2M | 4.6K | 0.96% | Trimmed(-7.3%) |
| 34 | M MAZE MAZE THERAPEUTICS INC | $4.1M | 136.6K | 0.93% | Added(+36.8%) |
| 35 | O OCFC OCULAR THERAPEUTIX INC | $4M | 408.5K | 0.91% | Trimmed(-7.5%) |
| 36 | O ORKA ORUKA THERAPEUTICS INC | $4M | 41.9K | 0.91% | Trimmed(-46.9%) |
| 37 | D DYN DYNE THERAPEUTICS INC | $3.8M | 172.0K | 0.87% | Trimmed(-6.0%) |
| 38 | E EWTX EDGEWISE THERAPEUTICS INC | $3.7M | 91.0K | 0.84% | Trimmed(-1.0%) |
| 39 | M MLTX MOONLAKE IMMUNOTHERAPEUTICS | $3.7M | 187.9K | 0.83% | Trimmed(-3.1%) |
| 40 | I INSM INSMED INC | $3.3M | 31.3K | 0.76% | Added(+28.5%) |
| 41 | C CLDX CELLDEX THERAPEUTICS INC NEW | $3.2M | 87.0K | 0.74% | Trimmed(-2.7%) |
| 42 | A AMZN AMAZON COM INC | $3.2M | 13.4K | 0.73% | Trimmed(-40.2%) |
| 43 | I IVEVF INVENTIVA SA | $3.1M | 831.4K | 0.72% | Added(+35.0%) |
| 44 | T TLN TALEN ENERGY CORP | $3.1M | 8.1K | 0.71% | Added(+161.3%) |
| 45 | R RLMD RELMADA THERAPEUTICS INC | $3.1M | 445.8K | 0.70% | — |
| 46 | P PB PROTAGONIST THERAPEUTICS INC | $3M | 24.5K | 0.68% | Trimmed(-27.7%) |
| 47 | E EQR ERASCA INC | $2.9M | 160.3K | 0.67% | Trimmed(-11.4%) |
| 48 | V VRDN VIRIDIAN THERAPEUTICS INC | $2.9M | 159.9K | 0.67% | Added(+19.1%) |
| 49 | H HPE-PC HEWLETT PACKARD ENTERPRISE C | $2.7M | 59.1K | 0.61% | Trimmed(-34.3%) |
| 50 | M MLYS MINERALYS THERAPEUTICS INC | $2.3M | 86.1K | 0.53% | Added(+84.0%) |